Gofen & Glossberg’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Gofen & Glossberg’s Portfolio MSOS Stock Details MSOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$84K	Buy	+12,000	New	+$123K	﹤0.01%	550
2022 Q3	–	Sell	-12,200	Closed	-$126K	–	584
2022 Q2	$126K	Buy	+12,200	New	+$181K	﹤0.01%	523
2021 Q4	–	Sell	-7,780	Closed	-$246K	–	632
2021 Q3	$246K	Buy	7,780 +895	+13%	+$31K	0.01%	493
2021 Q2	$275K	Buy	6,885 +815	+13%	+$33.1K	0.01%	455
2021 Q1	$257K	Buy	+6,070	New	+$280K	0.01%	447

Other funds holding MSOS

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ZIG

Zuckerman Investment Group Chicago, Illinois $1.07B AUM 29.43% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gofen & Glossberg's MSOS Position: Q4 2022 in Review

Gofen & Glossberg opened a new position in AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2022: 12,000 shares worth $84K. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings. This is a return to the name: Gofen & Glossberg previously reported a position in MSOS as recently as Q2 2022.

Gofen & Glossberg first reported a position in MSOS in Q1 2021 and has held it in 5 quarters since. The position peaked at $275K in Q2 2021. 176 funds tracked by Wall St. Rank hold MSOS as of Q4 2022.

Gofen & Glossberg held 12,000 shares of AdvisorShares Pure US Cannabis ETF worth $84K as of Q4 2022.
AdvisorShares Pure US Cannabis ETF was a new Gofen & Glossberg position in Q4 2022.
AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Gofen & Glossberg's portfolio in Q4 2022, its #550 holding.
Gofen & Glossberg first reported a position in AdvisorShares Pure US Cannabis ETF in Q1 2021 and has held it in 5 quarters since.
Gofen & Glossberg's AdvisorShares Pure US Cannabis ETF position peaked at $275K in Q2 2021.
176 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2022.

Based on Gofen & Glossberg's 13F filing for Q4 2022, filed 13 Jan 2023.